The Joao Xavier Lab

Finding

MSK Study Is the First to Link Microbiota to Dynamics of the Human Immune System

MSK researchers have shown for the first time that the concentration of different types of immune cells in the blood changes in relation to the presence of different bacterial strains in the gut.

At Work: Computational Biologist Joao Xavier

Computational biologist Joao Xavier combines computer models and laboratory experimentation to understand how cells interact.

Turning to Bacteria for Clues

Several Memorial Sloan Kettering investigators are focused on the study of bacteria, which can teach us much about human health, and about cancer in particular.

View All Featured News

View All Publications

Joao Xavier, PhD

Member, Computational & Systems Biology Program

• Systems biologist Joao Xavier combines experimental and computational approaches to study diverse problems relevant to cancer: how the microbiome influences cancer and cancer treatment, how cancer cells metastasize, and how metabolic fluxes command the behavior of living cells.
• PhD, Universidade Nova de Lisboa

[email protected]

Email Address

646-888-3195

Office Phone

Members

Yanyan Chen

Research Scholar

[email protected]

Ana Djukovic

Research Associate

[email protected]

Chen Liao

Research Scholar

Wendy Lin

Graduate Student

[email protected]

Deepti Mathur

Postdoctoral Research Fellow

[email protected]

Vishwas Mishra

Graduate Student

[email protected]

Nathaniel Campbell

Graduate Student

[email protected]

Henri Estanbouli

Laboratory Technician

Trinasia Kelly

Administrative Assistant

[email protected]

Jonas Schlueter

Postdoctoral Research Fellow

[email protected]

Bradford Taylor

Postdoctoral Research Fellow

[email protected]

Jinyuan Yan

Postdoctoral Research Fellow

[email protected]

Lab Alumni

Achievements

• Director's New Innovator Award, National Institutes of Health (2011)
• Biofilm Young Investigator Award, Center for Biofilm Engineering (2010)

Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.

MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.

Joao Xavier discloses the following relationships and financial interests:

The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.

This page and data include information for a specific MSK annual disclosure period (January 1, 2022 through disclosure submission in spring 2023). This data reflects interests that may or may not still exist. This data is updated annually.

Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].

View all disclosures